What is the recommended treatment for a male patient with a chlamydia infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chlamydia Infection in Males

For uncomplicated chlamydial urethritis in males, treat with either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days—both achieve 97-98% cure rates and are equally effective first-line options. 1, 2, 3

First-Line Treatment Selection

Choose between two equally effective regimens based on compliance concerns and cost:

  • Azithromycin 1 g orally, single dose is preferred when:

    • Compliance with a 7-day regimen is questionable 1, 2
    • Follow-up is unpredictable 1, 2
    • Directly observed therapy is needed 1, 3
    • The patient has erratic health-care-seeking behavior 1
  • Doxycycline 100 mg orally twice daily for 7 days is preferred when:

    • Cost is a primary concern (significantly less expensive than azithromycin) 2, 3
    • The patient can reliably complete a 7-day course 2
    • Rectal chlamydia is present or suspected (see below) 4, 5

Critical Implementation Steps

Maximize treatment success with these mandatory practices:

  • Dispense medications on-site when possible and directly observe the first dose 1, 2, 3
  • Instruct the patient to abstain from all sexual intercourse for 7 days after initiating treatment 6, 1, 2
  • Continue abstinence until all sex partners have completed treatment 1, 2, 3

Partner Management (Non-Negotiable)

All sex partners from the preceding 60 days must be evaluated, tested, and empirically treated—even if asymptomatic. 1, 2 If the last sexual contact was more than 60 days before diagnosis, still treat the most recent partner. 1, 3

Failing to treat sex partners leads to reinfection in up to 20% of cases. 1

Alternative Regimens (Only When First-Line Options Cannot Be Used)

Use these alternatives only when azithromycin and doxycycline are contraindicated or not tolerated:

  • Levofloxacin 500 mg orally once daily for 7 days 6, 1, 2
  • Ofloxacin 300 mg orally twice daily for 7 days 6, 1, 2
  • Erythromycin base 500 mg orally four times daily for 7 days 6, 1, 2
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 6, 1, 2

Important caveats about alternatives:

  • Erythromycin is less efficacious than first-line agents and causes frequent gastrointestinal side effects that reduce compliance 1, 2, 3
  • Levofloxacin has only 88-94% efficacy (inferior to 97-98% for first-line agents) and lacks clinical trial validation for chlamydia 1
  • Fluoroquinolones offer no compliance advantage over doxycycline (both require 7 days) and are more expensive 1

Special Consideration: Rectal Chlamydia

If rectal chlamydia is diagnosed or suspected in men who have sex with men, strongly prefer doxycycline over azithromycin. 4, 5

Recent high-quality evidence demonstrates:

  • Doxycycline achieves 96.9% cure rate for rectal chlamydia versus 76.4% for azithromycin (adjusted risk difference 19.9 percentage points, P<0.001) 4
  • Azithromycin-treated men had 5.2 times higher risk of persistent/recurrent rectal infection at 14-90 days compared to doxycycline 5

Follow-Up and Retesting

Do NOT perform routine test-of-cure for men treated with recommended regimens who are asymptomatic after treatment—cure rates exceed 97%. 1, 2, 3

DO perform repeat testing at 3 months after treatment for all men diagnosed with chlamydia, as reinfection rates are high (up to 39% in some populations). 1, 2, 3

Test-of-cure is only indicated when:

  • Therapeutic compliance is questionable 1, 3
  • Symptoms persist after treatment 1, 3
  • Reinfection is suspected 1, 3

If test-of-cure is performed, wait at least 3 weeks after treatment completion, as nucleic acid amplification tests performed earlier can yield false-positive results from dead organisms. 1, 2

Persistent or Recurrent Urethritis

If symptoms persist after completing treatment:

  • Do NOT retreat based on symptoms alone without documenting objective signs of urethral inflammation or laboratory evidence of infection 1
  • Consider testing for Mycoplasma genitalium using nucleic acid amplification test on first-void urine or urethral swab, as this organism causes doxycycline-resistant urethritis 1
  • For confirmed M. genitalium infection, treat with moxifloxacin 400 mg orally once daily for 7 days 1
  • Reverify that all sexual partners from the last 60 days were adequately treated 2

Concurrent Gonorrhea

If gonorrhea is confirmed or prevalence is high in the patient population, treat for both infections concurrently with ceftriaxone 250 mg IM single dose plus azithromycin 1 g orally single dose. 1 Coinfection rates are substantial, and treating chlamydia alone when gonorrhea is present leads to treatment failure. 1

Additional STI Testing

All patients diagnosed with chlamydia should be tested for gonorrhea, syphilis, and HIV at the initial visit. 1

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.